Rutgers researchers link GLP-1 diabetes and obesity drugs to a small increased risk of sudden vision loss from ischemic optic neuropathy, mostly in men aged 50 to 65.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.